Active Pharmaceutical Ingredients

The following section deals with Pharmaceutical Ingredients used for manufacturing the medicinal products


New API manufacturing facility will be established in the Tula region

On the sidelines of 22nd St. Petersburg International Economic Forum, Alexey Dyumin, the Governor of the Tula region, signed an agreement with Mikhail Shibaev, General Director of Efremov-Pharma LLC.

API market is expected to attain a valuation of $219,601.9 by the end of 2023

The report of Transparency Market Agency provides detailed qualitative analysis of the market dynamics that affect the growth of the global market.

Baltfarma may start producing pharma substances in St. Petersburg SEZ in 2021

On May 14, 2018, the expert council of St. Petersburg Special Economic Zone (SEZ) will review a business plan for building a plant to manufacture active pharmaceutical substances at Novoorlovskaya site.

Ardena boosts its API manufacturing capabilities by acquiring Syntagon

Contract development and manufacturing organisation (CDMO) Ardena has acquired Syntagon, a leading contract manufacturer of novel active pharmaceutical ingredients (APIs) and excipients.

AMRI launched its new aseptic API manufacturing line in Spain

The new line was announced in November 2017 and enhances capacity at the site while complementing AMRI’s other aseptic API manufacturing plants in Bon Encontre and Tonneins, France.
drug development

Codexis and Porton Pharma Solutions entered a strategic collaboration

Codexis and Porton Pharma Solutions announced a strategic collaboration to deploy Codexis’ world-leading biocatalyst technology within Porton’s global custom intermediate and API development and manufacturing business.


Expert opinion